Table 4 Clinical efficacy
| Â | H-LCL (n=) | E-LCL (n=) | H-LCL (n=) vs. E-LCL (n=) | ||||
|---|---|---|---|---|---|---|---|
Pre-op | Post-op | P Value | Pre-op | Post-op | P Value | P Value | |
AOFAS | 64.3 ± 16.2 | 81.3 ± 15.6 | 0.0091 | 67.1 ± 14.8 | 79.3 ± 16.2 | 0.0301 | > 0.05 |
SF-36 | 60.9 ± 19.7 | 79.6 ± 18.6 | 0.0185 | 59.8 ± 20.1 | 77.3 ± 19.4 | 0.0357 | > 0.05 |
Pain-NRS | 4.7 ± 1.9 | 2.3 ± 2.6 | 0.0044 | 5.0 ± 2.8 | 3.1 ± 2.8 | 0.0176 | > 0.05 |
UCLA | 5.3 ± 2.2 | 2.5 ± 2.1 | 0.0091 | 5.1 ± 2.8 | 3.7 ± 2.7 | 0.0401 | > 0.05 |